Bionet (1784) — Financial Flexibility Index
Bionet (1784) has a Financial Flexibility Index of 0.08x as of December 2025. Free cash flow of NT$66.48 Million (operating CF NT$28.46 Million minus capex NT$38.02 Million) represents 0% of total liabilities (NT$822.58 Million). Also explore how fast is Bionet growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bionet Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Bionet across 9 annual periods. Check 1784 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bionet (2017–2025)
Year-by-year free cash flow to debt coverage for Bionet. For the full company profile including market capitalisation, see market cap of Bionet.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | NT$280.22 Million | NT$148.04 Million | NT$822.58 Million | ▼ -7.5% |
| 2024 | 0.37x | NT$279.98 Million | NT$176.49 Million | NT$760.40 Million | ▲ +28.6% |
| 2023 | 0.29x | NT$179.38 Million | NT$153.09 Million | NT$626.47 Million | ▲ +15.4% |
| 2022 | 0.25x | NT$127.56 Million | NT$94.65 Million | NT$513.97 Million | ▲ +280.5% |
| 2021 | 0.07x | NT$30.54 Million | NT$13.88 Million | NT$468.19 Million | ▼ -74.0% |
| 2020 | 0.25x | NT$111.69 Million | NT$73.66 Million | NT$445.44 Million | ▲ +697.5% |
| 2019 | 0.03x | NT$14.27 Million | NT$2.67 Million | NT$453.87 Million | ▲ +282.0% |
| 2018 | 0.01x | NT$3.65 Million | NT$-12.97 Million | NT$443.09 Million | ▲ +124.9% |
| 2017 | -0.03x | NT$-14.96 Million | NT$-24.91 Million | NT$453.33 Million | — |